GlobalData
Data Collection & Internet Portals · United Kingdom · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
John Carpenter House, John Carpenter Str...Phone Number
+44 2079366400Website
www.globaldata.comRevenue
$426.3 MillionStock Symbol
DATAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About GlobalData
In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professions within corporations, financial institutions, professional services, and government agencies.Explore more
GlobalData Org Chart
PH
Head of Technology, & Professional Services (...
RG
Practice Head (Strategic Intelligence)
AM
Practice Head - Taxonomy
BR
Director, Software
SA
Director, Software
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GlobalData your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at GlobalData
Check out if GlobalData is spiking on competitors!
Click to see if GlobalData had a recent Job posting/layoffs
Check if GlobalData has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when GlobalData launches new products
Funding: Get notified immidiatlly once GlobalData has new funding data
Earning: See what the market has to say on GlobalData recently announced quarterly report
GlobalData, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
GlobalData is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
GlobalData is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about GlobalData.
GlobalData financials insights
Gather financial insights about GlobalData, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Debt
$425M
GlobalData Tech Stack
A closer look at the technologies used by GlobalData
Most Recent Scoops
Hiring Plans
GlobalData has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
GlobalData has more open roles in Sales than it has had at any time in the past 9 months. Technologies mentioned include: Gong, HubSpot, and Salesforce.
Hiring Plans
Hiring Plans
GlobalData has more open roles in Sales than it has had at any time in the past 9 months. Technologies mentioned include: Salesforce, and HubSpot. Areas of expertise include: Account Management, and Customer Success Management.
Hiring Plans
Hiring Plans
GlobalData has more open roles in Finance than it has had at any time in the past 12 months. Technologies mentioned include: GlobalData.
Hiring Plans
Open Position
GlobalData News & Media
Akeso and Summit’s ivonescimab meets OS goals in NSCLC
The drug has already been approved in China but is under review in the US with a PDUFA date of 14 November.AbbVie could take BiTE of Tecvayli market share on Phase III MM win
If approved, etentamig would join the increasingly competitive multiple myeloma market, which has seen the addition of several targeted therapies in recent years.ESC 2026: AstraZeneca’s oral relaxin agonist succeeds in Phase II trial
The win marks a milestone, given previous terminations in this drug class from AstraZeneca and Eli Lilly.
Read more news
Top Data Collection & Internet Portals Companies
See more top companies
Frequently Asked Questions Regarding GlobalData
Sign Up For FreeTo access detailed company insights
In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients... Read More
